Chicken pleiotrophin: Regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lee, Jin Young ^a   Jeong, Wooyoung ^a   Lim, Whasun ^a   Kim, Jinyoung ^a   Bazer, Fuller W ^a,b   Han, Jae Yong ^a   Song, Gwonhwa ^a  

^a Seoul National University   (South Korea)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; ESTROGEN; MESSENGER RNA; MICRORNA; MICRORNA 1709; MICRORNA 499; PLEIOTROPHIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOKINE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL TYPE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EGG; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC CONSERVATION; MAMMAL; NONHUMAN; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVIDUCT; PLEIOTROPHIN GENE; REGULATORY MECHANISM; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CHICKEN; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; MOLECULAR GENETICS; NEOPLASM; OVARY; OVARY TUMOR; PHYLOGENY; SEQUENCE HOMOLOGY;

GALLUS GALLUS; MAMMALIA;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CHICKENS; CYTOKINES; DNA METHYLATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; ORGAN SPECIFICITY; OVARIAN NEOPLASMS; OVARY; OVIDUCTS; PHYLOGENY; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84859344003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034215     Document Type: Article

References (76)

1. Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR, et al. (1989) A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 165: 1096-1103.
2. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, et al. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250: 1690-1694.
3. Muramatsu T, (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132: 359-371.
4. Perez-Pinera P, Chang Y, Deuel TF, (2007) Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts. Cell Cycle 6: 2877-2883.
5. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, et al. (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A 97: 2603-2608.
6. Chauhan AK, Li YS, Deuel TF, (1993) Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci U S A 90: 679-682.
7. Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A, (1992) Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem 267: 25889-25897.
8. Vacherot F, Caruelle D, Chopin D, Gil-Diez S, Barritault D, et al. (1999) Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate 38: 126-136.
9. Wu H, Barusevicius A, Babb J, Klein-Szanto A, Godwin A, et al. (2005) Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J Cutan Pathol 32: 125-130.
10. Jager R, Noll K, Havemann K, Pfluger KH, Knabbe C, et al. (1997) Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines. Int J Cancer 73: 537-543.
11. Dougherty DC, Sanders MM, (2005) Estrogen action: revitalization of the chick oviduct model. Trends Endocrinol Metab 16: 414-419.
12. Socher SH, Omalley BW, (1973) Estrogen-Mediated Cell-Proliferation during Chick Oviduct Development and Its Modulation by Progesterone. Developmental Biology 30: 411-417.
13. Palmiter RD, Wrenn JT, (1971) Interaction of Estrogen and Progesterone in Chick Oviduct Development. 3. Tubular Gland Cell Cytodifferentiation. Journal of Cell Biology 50: 598.
14. Bar A, (2009) Differential Regulation of Calbindin in the Calcium-Transporting Organs of Birds with High Calcium Requirements. Journal of Poultry Science 46: 267-285.
15. Hincke MT, Nys Y, Gautron J, (2010) The Role of Matrix Proteins in Eggshell Formation. Journal of Poultry Science 47: 208-219.
16. Song G, Seo HW, Choi JW, Rengaraj D, Kim TM, et al. (2011) Discovery of candidate genes and pathways regulating oviduct development in chickens. Biol Reprod 85: 306-314.
17. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19: 531-539.
18. Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, et al. (2008) Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 109: 115-121.
19. Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, et al. (2009) E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 113: 362-369.
20. Ahn SE, Choi JW, Rengaraj D, Seo HW, Lim W, et al. (2010) Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer. Reprod Biol Endocrinol 8: 100.
21. Lim W, Kim JH, Ahn SE, Jeong W, Kim J, et al. (2011) Avian SERPINB11 Gene: A Marker for Ovarian Cancer in Chickens. Experimental Biology and Medicine (in press).
22. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
23. Wong AS, Auersperg N, (2003) Ovarian surface epithelium: family history and early events in ovarian cancer. Reprod Biol Endocrinol 1: 70.
24. Cvetkovic D, (2003) Early events in ovarian oncogenesis. Reprod Biol Endocrinol 1: 68.
25. Goodman MT, Correa CN, Tung KH, Roffers SD, Cheng Wu X, et al. (2003) Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 97: 2648-2659.
26. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, et al. (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061.
27. Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih Ie M, (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 198: 351-356.
28. Kurman RJ, Shih Ie M, (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27: 151-160.
29. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC, (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288.
30. Murdoch WJ, Van Kirk EA, Alexander BM, (2005) DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp Biol Med (Maywood) 230: 429-433.
31. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC, (1998) The biology of ovarian cancer. Semin Oncol 25: 281-304.
32. Vanderhyden BC, Shaw TJ, Ethier JF, (2003) Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67.
33. Stakleff KD, Von Gruenigen VE, (2003) Rodent models for ovarian cancer research. Int J Gynecol Cancer 13: 405-412.
34. Song G, Seo HW, Choi JW, Rengaraj D, Kim TM, et al. (2011) Discovery of Candidate Genes and Pathways Regulating Oviduct Development in Chickens. Biol Reprod (in press).
35. Askew DJ, Cataltepe S, Kumar V, Edwards C, Pace SM, et al. (2007) SERPINB11 is a new noninhibitory intracellular serpin. Common single nucleotide polymorphisms in the scaffold impair conformational change. J Biol Chem 282: 24948-24960.
36. Lim W, Jeong W, Kim JH, Lee JY, Kim J, et al. (2011) Differential expression of alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas in chickens. Reprod Biol Endocrinol 9: 137.
37. Giles JR, Shivaprasad HL, Johnson PA, (2004) Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 95: 530-533.
38. Muramatsu T, (1993) Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37: 183-188.
39. Vigny M, Raulais D, Puzenat N, Duprez D, Hartmann MP, et al. (1989) Identification of a new heparin-binding protein localized within chick basement membranes. Eur J Biochem 186: 733-740.
40. Raulais D, Lagente-Chevallier O, Guettet C, Duprez D, Courtois Y, et al. (1991) A new heparin binding protein regulated by retinoic acid from chick embryo. Biochem Biophys Res Commun 174: 708-715.
41. Lai S, Czubayko F, Riegel AT, Wellstein A, (1992) Structure of the human heparin-binding growth factor gene pleiotrophin. Biochem Biophys Res Commun 187: 1113-1122.
42. Uehara K, Matsubara S, Kadomatsu K, Tsutsui J, Muramatsu T, (1992) Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem 111: 563-567.
43. Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, et al. (1995) Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121: 37-51.
44. Sakurai H, Bush KT, Nigam SK, (2001) Identification of pleiotrophin as a mesenchymal factor involved in ureteric bud branching morphogenesis. Development 128: 3283-3293.
45. Jung CG, Hida H, Nakahira K, Ikenaka K, Kim HJ, et al. (2004) Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. FASEB J 18: 1237-1239.
46. Amet LE, Lauri SE, Hienola A, Croll SD, Lu Y, et al. (2001) Enhanced hippocampal long-term potentiation in mice lacking heparin-binding growth-associated molecule. Mol Cell Neurosci 17: 1014-1024.
47. Hienola A, Pekkanen M, Raulo E, Vanttola P, Rauvala H, (2004) HB-GAM inhibits proliferation and enhances differentiation of neural stem cells. Mol Cell Neurosci 26: 75-88.
48. Muramatsu H, Zou P, Kurosawa N, Ichihara-Tanaka K, Maruyama K, et al. (2006) Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells 11: 1405-1417.
49. Brigstock DR, Kim GY, Steffen CL, (1996) Pig uterine luminal fluid contains the developmentally regulated neurotrophic factor, pleiotrophin. J Endocrinol 148: 103-111.
50. Brigstock DR, Kim GY, Steffen CL, Liu A, Vegunta RK, et al. (1996) High molecular mass forms of epidermal growth factor in pig uterine secretions. J Reprod Fertil 108: 313-320.
51. Kohler PO, Grimley PM, O'Malley BW, (1968) Protein synthesis: differential stimulation of cell-specific proteins in epithelial cells of chick oviduct. Science 160: 86-87.
52. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
53. Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, et al. (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila) 2: 114-121.
54. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE, (2007) CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104: 192-198.
55. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE, (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81: 373-379.
56. Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, et al. (2010) Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst 102: 26-38.
57. Johnson KA, (2009) The standard of perfection: thoughts about the laying hen model of ovarian cancer. Cancer Prev Res (Phila) 2: 97-99.
58. Kim HS, Lim W, Kim YB, Kim MA, Park YS, et al. (2011) SERPINB3 in the chicken model of ovarian cancer: a novel biomarker for predicting platinum resistance and survival in patients with epithelial ovarian cancer. The 97th Annual Congress of Korean Society of Obstetrics and Gynecology: Seoul, Republic of Korea.
59. Suzuki K, Oneyama C, Kimura H, Tajima S, Okada M, (2011) Down-regulation of the Tumor Suppressor C-terminal Src Kinase (Csk)-binding Protein (Cbp)/PAG1 Is Mediated by Epigenetic Histone Modifications via the Mitogen-activated Protein Kinase (MAPK)/Phosphatidylinositol 3-Kinase (PI3K) Pathway. J Biol Chem 286: 15698-15706.
60. Laird PW, Jaenisch R, (1994) DNA methylation and cancer. Hum Mol Genet 3 Spec No: 1487-1495.
61. Khalkhali-Ellis Z, (2006) Maspin: the new frontier. Clin Cancer Res 12: 7279-7283.
62. Jager R, List B, Knabbe C, Souttou B, Raulais D, et al. (2002) Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Br J Cancer 86: 858-863.
63. Souttou B, Juhl H, Hackenbruck J, Rockseisen M, Klomp HJ, et al. (1998) Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst 90: 1468-1473.
64. Klomp HJ, Zernial O, Flachmann S, Wellstein A, Juhl H, (2002) Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin Cancer Res 8: 823-827.
65. Soulie P, Heroult M, Bernard-Pierrot I, Caruelle D, Oglobine J, et al. (2004) Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detect Prev 28: 319-324.
66. Zhang N, Zhong R, Wang ZY, Deuel TF, (1997) Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant. J Biol Chem 272: 16733-16736.
67. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R, (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57: 1814-1819.
68. Lee SI, Lee WK, Shin JH, Han BK, Moon S, et al. (2009) Sexually dimorphic gene expression in the chick brain before gonadal differentiation. Poult Sci 88: 1003-1015.
69. Sanders MM, McKnight GS, (1988) Positive and negative regulatory elements control the steroid-responsive ovalbumin promoter. Biochemistry 27: 6550-6557.
70. Seo HW, Park JY, Lee HC, Kim D, Song YS, et al. (2009) Physiological Effects of Diethylstilbestrol Exposure on the Development of the Chicken Oviduct. J Anim Sci & Technol 51: 485-492.
71. Kohler PO, Grimley PM, O'Malley BW, (1969) Estrogen-induced cytodifferentiation of the ovalbumin-secreting glands of the chick oviduct. J Cell Biol 40: 8-27.
72. McKnight GS, (1978) The induction of ovalbumin and conalbumin mRNA by estrogen and progesterone in chick oviduct explant cultures. Cell 14: 403-413.
73. Song G, Bazer FW, Spencer TE, (2007) Pregnancy and interferon tau regulate RSAD2 and IFIH1 expression in the ovine uterus. Reproduction 133: 285-295.
74. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
75. Song G, Spencer TE, Bazer FW, (2006) Progesterone and interferon-tau regulate cystatin C in the endometrium. Endocrinology 147: 3478-3483.
76. Drummond AJ, Ashton B, Buxton S, Cheung M, Cooper A, et al. (2010) Geneious v5.04, Available fromhttp://www.geneious.com.